These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 11285028

  • 1. Epidemiologic and mucosal immunologic aspects of HPV infection and HPV-related cervical neoplasia in the lower female genital tract: a review.
    Tjiong MY, Out TA, Ter Schegget J, Burger MP, Van Der Vange N.
    Int J Gynecol Cancer; 2001; 11(1):9-17. PubMed ID: 11285028
    [Abstract] [Full Text] [Related]

  • 2. Human papillomavirus, it's genes...and cancer vaccines.
    Steller MA.
    Cancer Cell; 2003 Jan; 3(1):7-8. PubMed ID: 12559170
    [Abstract] [Full Text] [Related]

  • 3. Human papillomavirus as expressed in cervical neoplasia: evolving diagnostic and treatment modalities.
    Kenney JW, Reuss H.
    Health Care Women Int; 1994 Jan; 15(4):287-96. PubMed ID: 8056645
    [Abstract] [Full Text] [Related]

  • 4. HPV vaccine trial may take place in India.
    Sharma DC.
    Lancet Oncol; 2002 Nov; 3(11):649. PubMed ID: 12424057
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human papillomavirus infection with particular reference to genital disease.
    Sonnex C.
    J Clin Pathol; 1998 Sep; 51(9):643-8. PubMed ID: 9930065
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunity to oncogenic human papillomaviruses.
    Konya J, Dillner J.
    Adv Cancer Res; 2001 Sep; 82():205-38. PubMed ID: 11447764
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group.
    Franco E, Villa L, Rohan T, Ferenczy A, Petzl-Erler M, Matlashewski G.
    Rev Panam Salud Publica; 1999 Oct; 6(4):223-33. PubMed ID: 10572472
    [Abstract] [Full Text] [Related]

  • 16. The role of human papillomavirus vaccines in cervical neoplasia.
    Stern PL, Faulkner R, Veranes EC, Davidson EJ.
    Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):783-99. PubMed ID: 11563873
    [Abstract] [Full Text] [Related]

  • 17. [Human papillomavirus and cervical neoplasia].
    Rosa MI, Medeiros LR, Rosa DD, Bozzeti MC, Silva FR, Silva BR.
    Cad Saude Publica; 2009 May; 25(5):953-64. PubMed ID: 19488480
    [Abstract] [Full Text] [Related]

  • 18. Chapter 5: Viral and host factors in human papillomavirus persistence and progression.
    Wang SS, Hildesheim A.
    J Natl Cancer Inst Monogr; 2003 May; (31):35-40. PubMed ID: 12807943
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.